Sensome
Founded 2014 · 4 known investors
Sensome develops a microchip-based tissue-sensing technology that embeds bio-impedance sensors into minimally invasive medical devices to give physicians real-time, patient-specific data during procedures. Its lead product, the Clotild Smart Guidewire System, provides real-time blood clot characterization for acute ischemic stroke treatment, with additional applications in lung cancer biopsy and peripheral vascular intervention.
Deep TechHealthtechMedical Devices
Investors · 4
In the news
Frequently asked questions
- What does Sensome do?
- Sensome develops a microchip-based tissue-sensing technology that embeds bio-impedance sensors into minimally invasive medical devices to give physicians real-time, patient-specific data during procedures. Its lead product, the Clotild Smart Guidewire System, provides real-time blood clot characterization for acute ischemic stroke treatment, with additional applications in lung cancer biopsy and peripheral vascular intervention.
- Who are Sensome's investors?
- Sensome's investors include Kurma Partners, BNP Paribas Développement, Idinvest Partners, Paris-Saclay Seed Fund.